Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice
Description
Starting Parkinson's disease (PD) patients on subcutaneous apomorphine (APO) infusion is generally undertaken on a hospital day-case basis. During the COVID-19 pandemic, day-case facilities were unavailable. To avoid delays in treatment, a new
